Key facts
| Price (PPV) | 1,690 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | rasburicase |
| Class | All other therapeutic products |
| ATC code | V03AF07 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Boite de 3 flacons et de 3 ampoules |
| Nature | Médicament |
| Hospital price | 1,431 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement et prophylaxie de l’hyperuricémie aiguë, en vue de prévenir l’insuffisance rénale aiguë, chez les adultes, enfants et adolescents (âgés de 0 à 17 ans) souffrant d’une hémopathie maligne avec masse tumorale élevée et ayant un risque de réduction ou de lyse tumorale rapide lors de l’initiation de la chimiothérapie.
Find an open pharmacy
On-call pharmacies near you
About Fasturtec 1.5 mg / ml
Fasturtec 1.5 mg / ml belongs to the all other therapeutic products therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Fasturtec 1.5 mg / ml, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Fasturtec 1.5 mg / ml
Answers to common questions from Moroccan patients about this drug.